GP Teaching Afternoon Dr Asif Qasim 24 th September 2014.

Slides:



Advertisements
Similar presentations
Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
Advertisements

Case History 1 : Sorting out chest pain in general practice Dr Albert Ko / GP Panel.
National Service Frameworks Dr Stephen Newell February 2002.
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Stroke Mark Sudlow Consultant and Senior Lecturer
The Late Sodium Current in the cardiac myocite: How viable as a new therapeutic target in angina? SPONSORED SATELLITE SESSION Dr Stephen Holmberg Lead.
Valsartan Antihypertensive Long-Term Use Evaluation Results
Management of Acute Myocardial Infarction Minimal Acceptable vs Optimal Care Hussien H. Rizk, MD Cairo University.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Ischaemic Heart Disease for the GP Chris Tracey GPVTS.
Angina and MI.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
Dr Avinash Haridas Pillai
HEART FAILURE Prevalence increasing in our ageing population Incidence doubles with each decade between 40 and 80 At any age more common in men than women.
Arthur Stillman, M.D., Ph.D., PI Pamela Woodard, M.D., Study Co-chair Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
European guidelines on the management of stable coronary artery disease Key points & new position for Ivabradine and Trimetazidine ESC 2013 Montalescot.
Atrial Fibrillation Current Management Strategies.
‘Taxi Driver in Pain’ Tiara Gill Carrie Ross Mark Hambly.
Dr Jayachandran Thejus.  Coronary artery disease-  Block in coronary artery due to plaque or thrombus  Leads to myocardial ischemia manifested as chest.
Management of Stable Angina SIGN 96
VBWG OASIS-5 The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
Redefining Treatment Strategies for Optimal Medical Care in CAD COURAGE and MERLIN-TIMI 36.
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Heart failure: The national burden AHA. Heart disease and stroke statistics–2005 update. Koelling TM et al. Am Heart J. 2004;147:74-8. VBWG Affects 1 million.
Modern cardiology support for the acute oncology patient Chris Plummer Cardiology, Freeman Hospital.
Antithrombotic Trialists’ Collaboration An updated collaborative overview of randomised trials of antiplatelet therapy among high-risk patients.
Diagnosis, Management, & Follow-up Care Of CAD/AMI BARRY BERTOLET, MD CARDIOLOGY ASSOCIATES OF NORTH MS.
Journal Club Jeffrey P Schaefer, MD April 16, 2007.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
Internal Medicine Workshop Series Laos September /October 2009
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Stroke Dr Jane Molloy – Clinical Lead Stroke Services SRFT.
Cardiac update for GPs - Chest pain/angina Sanjay Sastry Consultant Cardiologist Royal Bolton Hospital Royal Bolton Hospital Manchester Heart Centre Wigan.
HEART FAILURE. Excellent Care 1. Diagnosis 2. ACE-I and B blocker 3. Aldosterone antagonist 4. Exercise 5. Statin and aspirin if CVD 6. Digoxin with AF.
Atrial Fibrillation: An old age problem PCCS Village Hotel 18 th May 2011.
Rapid assessment of chest pain Dr Phil Avery Prince Philip Hospital Hywel Dda Health Board PCCS 18 th May 2011.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Consistency in diagnostic and treatment procedures Specifically angiography and angioplasty Dr Alison Round 14 October 2015.
Women and Cardiovascular Disease
Cardiac causes of cardiac arrest
Total Occlusion Study of Canada (TOSCA-2) Trial
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
CORONARY ARTERY DISEASE
Complex Coronary intervention
CASE HISTORY ISCHEMIC HEART DISEASE
Life after a Cardiovascular Event
Unstable Angina and Non–ST Elevation Myocardial Infarction
NOACS: Emerging data in ACS/IHD
Preventive Angioplasty in Myocardial Infarction Trial
Impact of Platelet Reactivity Following Clopidogrel Administration
What oral antiplatelet therapy would you choose?
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Train-the-Trainer Cases
Train-the-Trainer Cases
Train-the-Trainer Cases
NICE 2014 Check pulse in patients presenting with:
Cardiovascular Epidemiology and Epidemiological Modelling
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

GP Teaching Afternoon Dr Asif Qasim 24 th September 2014

GP Teaching afternoon – Dr Asif Qasim – Update Real world cases Common situations with interface between hospital, GP and community care Questions and discussion – Workshop 1 – Heart Failure / Heart Rhythm – Coffee Break – Workshop 2 – Heart Rhythm / Heart Failure

Case 1: 57 years, female Presented to A+E with 90 minutes ischaemic chest pain at 8am No relevant PMH or regular medications Smoker cigarettes per day ECG – lateral ST depression Treated as Acute Coronary Syndrome Admitted directly to CCU

Case 1: 57 years, female Coronary angiography later that day Right radial approach Severe lesion in the first obtuse marginal Treated with PCI and stent implantation Plan for discharge

Case 1: 57 years, female What treatments reduce her risk of future events? 1.Antiplatelet therapy? 2.Statin? 3.ACE inhibitor? 4.Beta blocker? 5.Cardiac rehabilitation?

Case 1: 57 years, female Cardiac Rehabilitation 1.Smoking cessation 2.Diet – increase in F+V, weight reduction 3.Alcohol moderation 4.Exercise – tailored program 5.Proven reduction in morbidity and mortality

Case 1: 57 years, female Secondary prevention medications: 1.Statin 2.ACE Inhibitor 3.Beta-blocker?

Case 1: 57 years, female Anti-platelet therapy 1.Clopidogrel 2.Prasugrel 3.Ticagrelor

Case 1: 57 years, female Questions?

Case 2: 65M HTN, Ex-smoker – seen in RACPC 3/52Hx Central chest heaviness on walking up hill DHx Amlodipine 5mg OD Resting ECG TWF inferiorly CXR normal Exercise ECG: chest pain and ST depression in stage 2 Bruce Treated with Aspirin, Bisoprolol, Simvastatin Booked for coronary angiography

Angiogram

PCI and Stent to RCA

Nurse led PCI clinic and cardiac rehab There is evidence that exercise based cardiac rehabilitation reduces all cause and cardiac mortality and improves a number of cardiac risk factors Increased physical activity and combined dietary changes reduce mortality in coronary heart disease Taylor RS et al (2004). Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med;116:682-92Taylor RS et al (2004). Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med;116:682-92

Case 2:65M Did this patient get good care? Correct investigation? Appropriate treatment?

CG95 NICE CP of recent onset Recent onset chest pain ACS – urgent hospital assessment Exclude non cardiac chest pain Investigation for stable angina Pre-test probability of CAD No use of exercise ECG stress echo, CTA, MPI, Angiography

Risk stratification

CUH RACPC - Less invasive angiography -Greater differentiation between at-risk groups -More CT/ DSE -More interaction between primary and secondary care

CTA Stress echo

OMT vs revascularisation Courage study, NEJM (2007) 2287patients over 5 years >70% stenosis in 1+ epicardial coronary artery and evidence of myocardial ischemia or at least one coronary stenosis of at least 80% and classic angina without provocative testing. Randomly assigned to PCI or optimal medical therapy Success after PCI defined as angiographic success plus the absence of in- hospital myocardial infarction, emergency CABG, or death. Primary outcome - death from any cause and nonfatal myocardial infarction. Secondary outcomes - composite of death, MI / CVA and hospitalization for unstable angina with negative biomarkers

…but in COURAGE All patients had coronary angiography Half the patients had no evidence of ischaemia Less than 10% of screened patients were randomised Patients with critical lesions or strongly positive stress tests were excluded So the real conclusion from COURAGE: Patients with chest pain who might have angina and have moderate coronary lesions with possible ischaemia have the same outcome with PCI as medical therapy

OMT Aspirin and statin First line beta-blocker or Ca antagonist Add other agent or nitrate, nicorandil Emerging evidence for Ronalazine OMT – at least two anti-anginal agents

Prognostic CAD – should be revascularised Obstructive LMCA lesion Proximal three vessel disease Proximal severe LAD lesion Threatened occlusion >10% ischaemia burden on stress echo Consider use of pressure wire and FFR – FAME 1 and 2

CABG or PCI – MDM discussion Offer CABG for Prognostic disease symptoms despite OMT and PCI is not appropriate. Offer PCI for prognostic disease symptoms despite OMT and PCI is appropriate. Consider survival advantage of CABG over PCI for patients who are symptomatic despite OMT with Diabetes with MVD LMCA disease Complex multi-vessel disease

Questions

Case 3: 68 year old female  Atrial fibrillation – rate 110  Echo shows good LV and trivial MR. Dilated left atrium  No exertional symptoms  Aspirin only - No other regular medications  Previous TIA with speech disturbance 12 months previously  Normal CT, ECG and echo at that time

Case 3: 68 year old female  Rate or rhythm control?  Thrombo-embolic risk reduction?  Other tests?

Case 3: 68 year old female New oral anticoagulant drugs:  Dabigatran  Rivoroxaban  Apixaban

Case 3: 68 year old female

Case 4: 82 year old male  Admitted in June due to increasing SOB over 6 days and palpitations  Known IHD, CABG 15 years ago  known LV systolic dysfunction EF=30%  Permanent AF  O/E  AF110  JVP to the ears,  crackles to mid-zone  moderate ankle oedema  ECG AF rate  Baseline creatinine 150, hsTnT 45  CXR CCF, ULD, small right effusion

On admission medications Aspirin75mg Simvastatin 40mg Furosemide 80 mg od Spironolactone 25mg Could not tolerate b blockers Off ACE – hypotension Digoxin 125mcg Treated with iv Furosemide 80 mg bd, good response, lost 6 kg within a week, however creatinine increased Bisoprolol re introduced 1.25 and then 2.5 mg on 18/6

Planning for discharge Prolonged inpatient stay with iv diuretics for 26 days Seen by HF Specialist Nurses EF 30% on echo LBBB on ECG Consideration for CRT-D Advanced planning for end of life care Early FU with HF Specialist Nurses

How could we do better? Improving self care? Better community care? Health technology?

Self Care Patient education and support Understanding Heart Failure Fluid balance Patient self management Fluid intake and Urine output Daily weights Home heart rate and BP Diuretic dose adjustment Identifying exacerbations Red flags and worrying trends Seeking help early HF SN and early clinic access Better advanced planning Discussions about end of life

Community Care All CHS HF admissions to be seen by HF team Early HF SN community FU for all HF discharges Community iv diuretics Avoid admission Early discharge on iv diuretics CHS uniquely placed – national challenge in HF Better advanced planning

Health Technology Telephone clinics Telemetry at home Pulse ECG BP Respiratory rate Weight Device therapy – CRT Improved technology Broader indications Better advanced planning and end of life care

Single-Lead ECG Heart Rate Heart Rate Variability Respiratory Rate Skin Temperature Body Posture including Fall Detection Steps Stress Sleep Staging (Hypnogram) Cloud connectivity Close home monitoring Smart algorithms Home hospital….

Available in the coffee break